课题基金 / 基金详情

MECHANISMS OF EDEMA AND WEIGHT GAIN WITH PIOGLITAZONE

MECHANISMS OF EDEMA AND WEIGHT GAIN WITH PIOGLITAZONE
吡格列酮引起水肿和体重增加的机制
批准号：
7374176
负责人：
Robert Roy Henry
金额：
$11.98万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-04-01 至 2006-11-30
来源：
https://reporter.nih.gov/project-details/7374176
关键词：
balancebody weightedemafluidweight gain

项目摘要

项目成果

Robert Roy Henry的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。确定吡格列酮治疗对2型糖尿病患者体液平衡、外周水肿和体重的影响。确定吡格列酮治疗影响体液平衡、水肿和体重的机制，与血糖控制效果无关
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the effects of pioglitazone therapy in type 2 diabetics on fluid balance, peripheral edema, and body weight. Determine the mechanisms by which pioglitazone treatment influences fluid balance, edema and body weight, independent of effects on glycemic control
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
海外基金